Clinical Trials Directory

Trials / Completed

CompletedNCT06933797

Evaluation of the Potential Effects of LRP5 and Tph1 in the Pathogenesis of Periodontal Disease Individuals With Stage III Grade B Periodontitis

Evaluation of the Changes in LRP5 and TPH1 Levels Due to Periodontal Inflammation

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Ankara University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Objectives: The aim of this study was to determine the changes in LRP5 and TPH1 levels in serum and saliva samples due to periodontal inflammation and to evaluate the relationship between these values and clinical periodontal parameters. Methods: Saliva and serum samples were collected from 20 systemically healthy patients with Stage III periodontitis and 20 periodontally healthy control individuals. Salivary and serum LRP5 and TPH1 levels were analyzed using enzyme-linked immunosorbent assay (ELISA). Clinical periodontal parameters, including plaque index (PI), probing pocket depth (PPD), bleeding on probing (BOP), and clinical attachment level (CAL), were recorded.

Conditions

Timeline

Start date
2024-04-01
Primary completion
2024-10-01
Completion
2025-02-25
First posted
2025-04-18
Last updated
2025-04-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06933797. Inclusion in this directory is not an endorsement.

Evaluation of the Potential Effects of LRP5 and Tph1 in the Pathogenesis of Periodontal Disease Individuals With Stage I (NCT06933797) · Clinical Trials Directory